Sep 05, 2014
1:3
For every 3 shares held, investors received 1.
The split itself did not change the total investment value.
Fennec Pharmaceuticals Inc. (GETTEX:RV41) operates in the Biotechnology industry.
Fennec Pharmaceuticals Inc. company overviewFennec Pharmaceuticals Inc.'s most recent stock split was on September 5, 2014. It was a 1-for-3 reverse split, so shareholders received 1 share for every 3 they held.
Fennec Pharmaceuticals Inc. (GETTEX:RV41) has split its stock 3 times: a 1-for-5 reverse split on August 2, 2005, a 1-for-18 reverse split on August 30, 2011, and a 1-for-3 reverse split on September 5, 2014.
Fennec Pharmaceuticals Inc. has split its stock 3 times. This history records 3 reverse splits between August 2, 2005 and September 5, 2014.
A reverse stock split combines several shares into one and raises the price per share by the same factor, so the total value of a holding does not change. In Fennec Pharmaceuticals Inc.'s 1-for-3 reverse split on September 5, 2014, every 3 shares became one share. Companies often use reverse splits to lift a low share price, for example to keep meeting an exchange's minimum price requirement.
Fennec Pharmaceuticals Inc. has not announced a new split in our records. Its most recent split was on September 5, 2014, 12 years ago. Companies announce splits in advance, and any new GETTEX:RV41 split will appear on this page.